Sinopharm Group Co Ltd X2S
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €1.76
- Day Range
- €1.78–1.78
- 52-Week Range
- €1.67–—
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 3.12B
- Market Cap
- CN¥5.56B
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 5.54
- Price/Sales
- 0.07
- Dividend Yield (Trailing)
- 4.88%
- Dividend Yield (Forward)
- 4.88%
- Dividend Payment Schedule
- Aug
- Total Yield
- 4.88%
Company Profile
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm’s largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm’s total revenue. Sinopharm’s downstream customers range from hospitals and other health services institutions to end-customers.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Mid Value
- Total Number of Employees
- 90,447
- Website
- http://www.sinopharmgroup.com.cn
Valuation
|
Metric
|
X2S
|
|---|---|
Price/Earnings (Normalized) | 5.54 |
Price/Book Value | 0.48 |
Price/Sales | 0.07 |
Price/Cash Flow | 3.01 |
Price/Earnings
X2S
Financial Strength
|
Metric
|
X2S
|
|---|---|
Quick Ratio | 1.10 |
Current Ratio | 1.40 |
Interest Coverage | 7.93 |
Quick Ratio
X2S
Profitability
|
Metric
|
X2S
|
|---|---|
Return on Assets (Normalized) | 3.37% |
Return on Equity (Normalized) | 16.40% |
Return on Invested Capital (Normalized) | 6.88% |
Return on Assets
X2S
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|&c$Y$!% | LOCK|zQfg | $117B | |||
| Cencora Inc
COR
| LOCK|##WKBSk | LOCK|@@rW | $65B | |||
| Cardinal Health Inc
CAH
| LOCK|ZC^$tL@ | LOCK|@dX># | $59B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|&n%q | $23B | |||
| Henry Schein Inc
HSIC
| LOCK|XW$dFp | LOCK|!lZ< | $10B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|!SQ | $8B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|p! | $6B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|dd | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|Ll$% | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|l^ | $4B |
United States